Cryoglobulinemia
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Cryoglobulinemia Classification and external resources | |
| ICD-10 | D89.1 |
|---|---|
| ICD-9 | 273.2 |
| DiseasesDB | 3207 |
| MedlinePlus | 000540 |
| eMedicine | med/480 |
| MeSH | D003449 |
|
WikiDoc Resources for Cryoglobulinemia | |
|
Articles | |
|---|---|
|
Most recent articles on Cryoglobulinemia Most cited articles on Cryoglobulinemia | |
|
Media | |
|
Powerpoint slides on Cryoglobulinemia | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Cryoglobulinemia at Clinical Trials.gov Trial results on Cryoglobulinemia Clinical Trials on Cryoglobulinemia at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Cryoglobulinemia NICE Guidance on Cryoglobulinemia
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Cryoglobulinemia Discussion groups on Cryoglobulinemia Patient Handouts on Cryoglobulinemia Directions to Hospitals Treating Cryoglobulinemia Risk calculators and risk factors for Cryoglobulinemia
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Cryoglobulinemia | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Businness | |
|
Experimental / Informatics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2] Phone:617-525-7431
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Cryoglobulinemia is the presence of high amount of heavy globulins (e.g. IgM) in the bloodstream which thicken or gel on exposure to cold. Cryoglobulins are circulating immunoglobulins or proteins that become insoluble at less than 4 degrees Celsius. The reaction is reversible; redissolution occurs at 37 degrees Celsius. Such proteins are called cryoglobulins. Cryoglobulinemia can lead to a medium-sized vessel vasculitis due to vascular deposition of circulating immune complexes. This leads to the triad of palpable purpura, arthralgias and peripheral neuropathy. The relationship of cryoglobulins and hepatitis C infection as well as B cell neoplasia provides an interesting link between infection, autoimmune disease and lymphoproliferative disorders.
Classification
Cryoglobulinemia is classically grouped into three types according to the Brouet classification.[1]
Type I
Type I is is a monoclonal immunoglobulin and is most commonly encountered in patients with a plasma cell dyscrasia such as multiple myeloma or Waldenström macroglobulinemia.[1] It can lead to a glomerulopathy that is distinct from light chain disease in amyloidosis.
Type II
Type II is essential mixed cryoglobulinemia and the cryoglobulins are a polyclonal IgG and a momoclonal IgM rheumatoid factor directed against IgG. Epstein-Barr Virus (EBV), HIV and Hepatitis B have been implicated but the majority is due to Hepatitis C (HCV). [1]
Type III
Type III is also a mixed cryoglobulinemia (MC) where both the IgG and IgM are polyclonal. It is seen in various autoimmune disorders and lymphoreticular disease as well as hepatitis C in almost 50%. There is a 50% mortality rate at 15 years after diagnosis of MC.
Differential Diagnosis of Associated Disease States
Cryoglobulins may be present in mycoplasma pneumonia, multiple myeloma, certain leukemias, primary macroglobulinemia, and some autoimmune diseases, such as systemic lupus erythematosus and rheumatoid arthritis. This is also found occasionally as a symptom in 35% of chronic hepatitis C infections.[1]
Pathophysiology & Etiology
It is important to note that these two different, yet highly representative, clinical syndromes generally reflect different types of underlying CG:
- Hyperviscosity is typically associated with CG due to hematological malignancies and monoclonal immunoglobulins.
- "Meltzer's triad" of palpable purpura, arthralgia and myalgia is generally seen with polyclonal CGs seen in essential-, viral-, or connective tissue disease-associated CG.
- MC is closely associated with hepatitis C infection and is thought to activate B lymphocytes by binding to CD81.
- 80-95% of patients with MC have circulating anti-HCV antibodies or circulating HCV RNA in the serum or within the cryoprecipitate.
- Polyclonal IgG anti-HCV have been noted in the cryoprecipitate as well.
- Approximately 50% of patients with chronic hepatitis C and 15% with hepatitis B will have circulating MC (1/2 Type II, 2/3 Type III).
- It is unclear what the antigen trigger is for production of the MC, but it is though that the hepatitis C viral RNA itself may be the factor since it is found in high quantities in the cryoprecipitate.
History and Symptoms
- Palpable purpura, arthralgias, and neuropathy are common findings.
- Nonspecific systemic complaints, hepatosplenomegaly and hypocomplementemia are noted.
- Low-grade Non-Hodgkins lymphomas may occur with increased frequency among these patients.
- Renal disease occurs in 20% of patients at diagnosis and eventually develops in up to 60%, usually after the development of purpura.
- Renal involvement is more common in Type II than Type III MC.
- Most patients present with ayamptomatic hematuria and poteinuria, but frank nephrotic syndrome and acute renal failure can develop.
- The characteristic findings on renal biopsy are
- Intraluminal thrombi
- Diffuse IgM deposition in the capillary loops
- Subendothelial deposits in a “curvilinear” pattern on EM.
- Only 14% develop end stage renal disease (ESRD) at 10 years after a renal biopsy demonstrates MC.
- Recurrent MC can affect up to 70% of transplanted kidneys, but does not preclude transplantation since most of these grafts do not fail.
Laboratory Findings
Electrolyte and Biomarker Studies
- At least 20cc of blood should be drawn in the fasting state (lipids interfere) and sent to the lab in warm water.
- The blood is spun at body temperature then the serum is cooled to see if a precipitate develops.
- “Cryocrits” of up to 50% have been noted.
- The cryoprecipitates is then analyzed for type of immune complex by immunofixation.
- If anti-HCV and HCV RNA are negative but hepatits C is still suspected, the cryoprecipitate can be assayed directly for HCV RNA and anti-HCV antibody.
- Spurious leukocytosis and thrombocytosis from the cryoglobulin particles have been noted if the sample is tested a lower temperature.
- White blood cell count (WBC) of >40K normalize with warming of the blood.
- The blood is spun at body temperature then the serum is cooled to see if a precipitate develops.
Other Diagnostic Studies
Skin biopsy can be of value in establishing the diagnosis.
Treatment
- The main indication for therapy is progressive end organ disease.
Acute Pharmacotherapies
- Outside of the acute setting, immunosuppresive agents are thought to worsen the course of MC associated with HCV.
- Interferon-alfa and ribavirin have been used in combination.
- MC response, predictably, was related to the response rate of the underlying HCV to these agents.
- Ribavirin should not be used in patients with glomerular filtration rate (GFR) <50 cc/min.
Future or Investigational Therapies
- In patients with acute, severe disease, plasmapheresis has been used in conjunction with high dose steroids and cytoxan.
- Uncontrolled studies demonstrated a reduction in creatinine in up to 87% of patients.
Acknowledgements
The content on this page was first contributed by: Editor-In-Chief: C. Michael Gibson, M.S., M.D. [4] Phone:617-525-6884
References
See also
External links
Blood | |
|---|---|
| General | Plasma – Hematopoietic stem cells |
| Lymphoid – WBC | T cells: Cytotoxic CD8+, Helper CD4+/Regulatory, γδ, Natural Killer T cell
Natural killer cells (Lymphokine-activated killer cell) Null cell |
| Myeloid – WBC | Monocytes/Macrophages (Histiocytes, Kupffer cells, Dust cell, Microglia, Osteoclasts, Epithelioid cells, Langhans giant cells, Foreign-body giant cell)
Granulocytes (Neutrophil, Eosinophil, Basophil) – Mast cell precursors Dendritic cells (Langerhans cells, Follicular dendritic cells) Megakaryoblast – Megakaryocyte – Platelets |
| Myeloid – RBC | Reticulocyte – Normoblast |
WikiDoc Research Resources for Cryoglobulinemia | |
|---|---|
| Articles on Cryoglobulinemia | Most recent articles on Cryoglobulinemia • Most cited articles on Cryoglobulinemia • Review articles on Cryoglobulinemia • Articles on Cryoglobulinemia in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Cryoglobulinemia | Powerpoint slides on Cryoglobulinemia • Images of Cryoglobulinemia • Photos of Cryoglobulinemia • Podcasts & MP3s on Cryoglobulinemia • Videos on Cryoglobulinemia |
| Evidence Based Medicine Regarding Cryoglobulinemia | Cochrane Collaboration on Cryoglobulinemia • Bandolier on Cryoglobulinemia • TRIP on Cryoglobulinemia |
| Cost Effectiveness of Cryoglobulinemia | Cost Effectiveness of Cryoglobulinemia |
| Clinical Trials Involving Cryoglobulinemia | Ongoing Trials on Cryoglobulinemia at Clinical Trials.gov • Trial results on Cryoglobulinemia • Clinical Trials on Cryoglobulinemia at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Cryoglobulinemia | US National Guidelines Clearinghouse on Cryoglobulinemia • NICE Guidance on Cryoglobulinemia • NHS PRODIGY Guidance • FDA on Cryoglobulinemia • CDC on Cryoglobulinemia |
| Textbook Information on Cryoglobulinemia | Books and Textbook Information on Cryoglobulinemia |
| Pharmacology Resources on Cryoglobulinemia | Dosing of Cryoglobulinemia • Drug interactions with Cryoglobulinemia • Side effects of Cryoglobulinemia • Allergic reactions to Cryoglobulinemia • Overdose information on Cryoglobulinemia • Carcinogenicity information on Cryoglobulinemia • Cryoglobulinemia in pregnancy • Pharmacokinetics of Cryoglobulinemia • |
| Genetics, Pharmacogenomics, and Proteinomics of Cryoglobulinemia | Genetics of Cryoglobulinemia • Pharmacogenomics of Cryoglobulinemia • Proteomics of Cryoglobulinemia |
| Newstories on Cryoglobulinemia | Cryoglobulinemia in the news • Be alerted to news on Cryoglobulinemia • News trends on Cryoglobulinemia |
| Commentary on Cryoglobulinemia | Blogs on Cryoglobulinemia |
| Patient Resources on Cryoglobulinemia | Patient resources on Cryoglobulinemia • Discussion groups on Cryoglobulinemia • Patient Handouts on Cryoglobulinemia • Directions to Hospitals Treating Cryoglobulinemia • Risk calculators and risk factors for Cryoglobulinemia |
| Healthcare Provider Resources on Cryoglobulinemia | Symptoms of Cryoglobulinemia • Causes & Risk Factors for Cryoglobulinemia • Diagnostic studies for Cryoglobulinemia • Treatment of Cryoglobulinemia |
| Continuing Medical Education (CME) Programs on Cryoglobulinemia | CME Programs on Cryoglobulinemia |
| International Resources on Cryoglobulinemia | Cryoglobulinemia en Espanol • Cryoglobulinemia en Francais |
| Business Resources on Cryoglobulinemia | Cryoglobulinemia in the Marketplace • Patents on Cryoglobulinemia |
| Informatics Resources on Cryoglobulinemia | List of terms related to Cryoglobulinemia |
de:Kryoglobulinämie fr:Cryoglobulinémie
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
